Thomas Forest Farb-Horch has over three decades of experience as an investor in and senior executive of numerous life science and information technology companies both in the US and internationally.
Farb has served as the chief executive officer, president, co-founder and director of Thrive Bioscience, Inc. since May 2014.
He has also served as president, chief operating officer and in other C-level positions at several other companies, including Interneuron Pharmaceuticals (NASDAQ), Indevus Pharmaceuticals (NASDAQ), and Cytyc (NASDAQ).
Farb currently serves on the boards of directors of North Shore InnoVentures and AutoImmunity Biologic Solutions, and is a member of the scientific advisory board of Emervax.
Farb previously served on the boards of directors of Fair Isaac (NYSE: FICO), Redwood Trust (NYSE: RWT), HNC Software (NASDAQ), Retek Systems (NASDAQ) and Symon Communications (NASDAQ). Farb earned a B.A. in sociology from Harvard University.
Agnieszka Winkler has extensive professional and board experience with start-up, mid-cap and Fortune 500 companies. Winkler currently serves on the board of directors of Virco (NASDAQ: VIRC) and the board of trustees of each of Santa Clara University and the African Diaspora Network.
She also serves as chair of the board of directors of the Jesuit School of Theology and as president of the board of Catholic Charities of Santa Clara County.
Winkler has previously served on numerous public company boards such as SuperCuts (NASDAQ), Reno Air (NASDAQ), The Cheesecake Factory (NASDAQ: CAKE), and Inter-Tel (NASDAQ), as well as private company boards including Ascension, a USD 22bn healthcare system, Ascension Network and IPLocks.
She was the founder and former chair and chief executive officer of TeamToolz, a software company, and Winkler Advertising, both of which were acquired.
Winkler earned a B.A. in history from Holy Names University, an M.A. in history from San Jose State University, and an M.B.A. from Santa Clara University.
Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics.
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Enable Biosciences names new chief financial officer
Cadenza Bio names new director
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation